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AbstrACt
Objective Hospital at home (HAH) for chronic obstructive 
pulmonary disease exacerbation selected by low-risk 
Dyspnoea, Eosinopenia, Consolidation, Acidaemia and atrial 
Fibrillation (DECAF) score is clinical and cost-effective; DECAF 
is a prognostic score indicating risk of mortality. Up to 50% 
of admitted patients are suitable, a much larger proportion 
than earlier services. Introduction of new models of care is 
challenging, but may be facilitated by informed engagement 
with stakeholders. This qualitative study sought to identify 
facilitators and barriers to implementation of HAH.
Design Semistructured interviews, data were analysed using 
thematic-construct analysis.
setting Interviews were conducted within patients’ homes and 
hospitals in North East England.
Participants 89 participants were interviewees; 44 patients, 
15 carers, 15 physicians, 11 specialist nurses and 4 managers.
results Facilitators include the following: (1) availability of 
home comforts and maintaining independence (with positive 
influences on perceived rate of recovery, sleep quality and 
convenience for friends, family and carers) and (2) confidence 
in the continuity of HAH care. Barriers include the following: 
(1) fear of being alone at home; (2) privacy issues and not 
wanting visitors and (3) resistance to change. Clinician concerns 
occasionally delayed return home, principally during the early 
phase of the trial. Nurses cited higher workload and greater 
responsibility, but with additional resource and training; overall, 
they viewed HAH positively. Operational concerns included 
keeping medical records in a patient's home and inability to 
capture activity within current payment systems.
Conclusion HAH selected by DECAF was preferred to inpatient 
care by most patients and their families. Implementation in 
other hospitals will require education, training and service 
planning, tailored to overcome the identified barriers.
trial registration number ISRCTN29082260.
IntrODuCtIOn  
In a randomised controlled trial (RCT), we 
have shown that hospital at home (HAH) 
selected by the Dyspnoea, Eosinopenia, 
Consolidation, Acidaemia and atrial Fibrilla-
tion (DECAF) prognostic score is cost-effec-
tive, safe and preferred by 90% of patients.1 
DECAF is a prognostic score that can be used 
to assess the inpatient risk of death in those 
with a chronic obstructive pulmonary disease 
exacerbation (ECOPD) using indices that are 
routinely available at admission: DECAF. It 
offers excellent performance and identifies 
a large proportion of patients (45%–53%) as 
low risk (DECAF 0–1) and therefore candi-
dates for HAH.2 3 This is of importance as 
ECOPD accounts for over one million ‘bed 
days’ in UK hospitals each year and are asso-
ciated with substantial morbidity and cost.4–6 
In ECOPD, key differences of HAH to early 
supported discharge (ESD) are the inclu-
sion of patients with higher medical depen-
dency, replacing all or most of the inpatient 
stay and the provision of 24/7 support. The 
National Institute for Health and Care Excel-
lence endorse both services in patients with 
a low risk of death.7 In an era of spiralling 
strengths and limitations of this study
 ► A large number of interviews were performed using 
purposeful sampling to ensure a wide range of par-
ticipants and perspectives.
 ► Member checking was performed on physicians.
 ► Interviews were conducted by a health psychologist 
separate to the clinical team to minimise the risk of 
observer bias.
 ► There is a risk of social desirability bias with inter-
viewees telling us that which we wish to hear.
 ► The study was conducted within a UK healthcare 
setting and may not be representative to other coun-
tries implementing a hospital at home care pathway.
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healthcare demands and costs, providers are open to new 
models of care.8 Qualitative studies aid implementation 
of novel clinical services and add validity to the results of 
RCTs.9 10 Within our RCT, we undertook an embedded 
qualitative study to identify positive drivers and potential 
barriers to HAH for ECOPD selected by DECAF and assist 
wider implementation.
MethODs
Participants
Participants included patients within the HAH and usual 
care (UC) arms of the RCT, their carers, patients who 
declined enrolment in the RCT, clinicians and hospital 
managers. Patients in HAH and UC were purposively 
selected (CE and LD) in relation to gender, age, socio-
economic background, chronic obstructive p ulmo-
nary disease (COPD) severity (ie, breathlessness by the 
extended, modified research council dyspnoea score; 
forced expiratory flow volume in 1 s and previous admis-
sions) and reasons for their preferred place of care. All 
respiratory specialist nurses (RSNs) and consultants, 
and key acute physicians and managers were invited. 
Ethical approval was granted by NRES Committee North 
East-Sunderland (Ref: 13/NE/0275) and the trial was 
registered (ISRCTN: 290082260). Participants received 
a telephone call to confirm participation in interviews, 
informed consent was obtained for the interviews and all 
participants were anonymised/given pseudonyms.
Semistructured interviews were carried out with 89 
participants, which included 44 patients, 15 carers, 15 
physicians, 11 RSNs and 4 managers (Hospital: General 
Manager, operational service manager and finance. 
Community: Adult Social Care manager). Eight patients 
and carers were interviewed together at their request; all 
other interviews were one-to-one. One study participant 
was interviewed in hospital, all other participants and 
carers were interviewed in their home. Participant charac-
teristics are shown in table 1. The term ‘decliners’ refers 
to patients who declined participation in the RCT, but 
consented to interview within this study. Most decliners 
were interviewed in hospital. Interviews were conducted 
until data saturation was reached.
Patients participating in the RCT who had a carer 
(unpaid individual who helped with daily needs) were 
identified. Carers were asked to complete the Zarit 
Burden Interview at baseline, 14 days and 90 days. The 
Zarit Burden Interview is a multidimensional scale that 
measures caregiver burden. We planned to present the 
median values and data range by group, without inferen-
tial statistics.
Interviews
Prior to the RCT, the interview schedules were developed 
within a pilot HAH service and further informed by feed-
back from inpatients recovering from ECOPD. The final 
semistructured interview schedule (see online supple-
mentary file) contained a series of open-ended questions, 
such as, ‘If in the future HAH is routinely available, would 
you choose to have treatment at home or in the hospital 
and why?’
The interviews were designed to explore patients’ 
experience of receiving HAH and UC, preference and 
perceived influencing factors. The role of the carer 
within both structures of care and carer burden was 
assessed. Clinical and organisational factors that impact 
on professional’s experiences were explored. Patient and 
carer interviews were arranged postdischarge, and all 
interviews were audio-recorded and transcribed verbatim.
In the subgroup of decliners, interviews were shorter 
and more focused on issues related to participation with 
HAH.
Participants experiences of HAH and UC were explored, 
with an aim to uncover the drivers and barriers towards 
the new care pathway; therefore, the transcripts were 
analysed using a combined inductive-deductive method 
known as ‘thematic-construct analysis’.11 Data were read 
for communalities working from a critical perspective.
Researchers remained as faithful as possible to the 
participants’ own accounts using an inductive approach 
while looking deductively for discourses that were in line 
with positive drivers and potential barriers of the new 
Table 1 Description of participants
Participant role n Description
Patients participating 31 16 from UC, 15 from HAH. Mean (SD) age=68 (10) years; 52% women; median (IQR) eMRCD 
score=4 (3–4); mean (SD) FEV1=43.4 (18.7) per cent predicted and previous admissions for an 
exacerbation=0 (0–2)
Decliners 13 Mean (SD) age=73 (11) years; 77% women; median (IQR) eMRCD score=4 (4–4)
Carers 15 Mean (SD) age=61 (11) years, 53% women, 80% were the patient’s partner. Five carers’ relatives 
received UC and 10 carers’ relatives received HAH
RSNs 11 Mean (SD) age=39 (11) years, 100% women, mean (SD) years’ experience=7 (5) years
Physicians 15 11 respiratory consultants, three acute care physicians and one specialist registrar; mean (SD) 
age=41.5 (6) years, 71.4% were men, mean (SD) years reported experience=12 (6)n years
Managers 4 Three secondary and one social care; mean (SD) age=50 (2) years, 50% were women
eMRCD, breathlessness score; FEV1, forced expiratory volume; HAH, hospital at home; RSNs, respiratory specialist nurses; UC, usual care.
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care pathway. Each interview transcript was read and 
re-read by three authors (LLD, AvW and SB) to ensure 
familiarisation with the data; the authors independently 
coded the data and identified themes. The interpreta-
tions were discussed, and the final themes and subthemes 
were agreed on (see box 1).
Member checking was performed with physicians due to 
non-familiarity of the new care model. All physicians were 
sent their own transcripts and asked whether they still 
agreed with their responses to which three agreed to be 
interviewed again. Member checking was not performed 
in other groups because interviews with patients and 
nurses were longer, they were all familiar with the care 
provided, numbers were larger and we did not want to 
overburden individuals.
Decliners were interviewed (with consent) to elicit their 
reasons for declining enrolment in the RCT and whether 
they would consider HAH in the future, if shown to be 
safe and effective.
Clinical structure of care
Hospital at home
HAH provides care for patients within their home for a 
condition that would otherwise require inpatient care.12 
HAH involved treating patients at home supported by a 
nurse-led respiratory specialist service, after a brief inpa-
tient assessment. Patients were not regarded as sufficiently 
well for discharge. Further information on the service is 
available including structured clinical assessment sheets 
and the HAH manual within the online supplementary 
file of the RCT.1
Usual care
Patients were managed in accordance with usual hospital 
care. We engaged with clinical staff, emphasising that 
clinical decisions should not be influenced by trial 
participation.
Patient and public involvement
The semistructured research interviews, intervention 
(HAH) and outcome measures were informed by inter-
views with patients and family members, including carers. 
Most were happy with treatment within HAH provided 
this was safe. Key concerns with HAH were as follows: clin-
ical deterioration at home, delayed treatment and lack of 
social support/increased carer burden. Direct telephone 
contact, 24/7, to the respiratory team and the availability 
of same day social support addressed these issues. Further-
more, we used a validated tool to assess carer burden. 
An expert patient and non-expert patients informed the 
selection of health-related questionnaires and measures of 
service acceptability. Patients with acute ECOPD assessed 
different home-monitoring devices for acceptability and 
comfort and reviewed the written description of HAH for 
clarity which informed the patient information sheet.
results
Quotes which best presented the established constructs 
were identified by capital letters using scripts from 
patients (P), decliners (D), carers (C), consultants (Co), 
RSN (N) and managers (M). The Respiratory Specialist 
Registrar’s comments were coded Co for anonymity. 
Quotations have been shortened; both the full quotation 
and additional supporting quotations are provided in the 
online supplementary file. All patients that were inter-
viewed survived to the end of the study.
Positive drivers for hAh
Availability of home comforts and maintaining independence
Patients, carers and RSNs consistently highlighted that 
patients were comfortable in their home, with positive 
influences on mood and confidence. Hospital routines 
were avoided, and patients maintained their inde-
pendence by engagement in usual activities. Patients 
requiring oxygen noted that the equipment provided 
within HAH allowed free movement while provision in 
hospital limited mobility. ‘I couldn’t even walk up the 
ward… I only had this like little lead… I can go upstairs 
(at home)… it’s nice and I can get up and make myself a 
meal’ (P22L145–153).
Perception of a quicker recovery with HAH and positive effects on 
perceived breathlessness
Patients and carers perceived that recovery occurred more 
quickly during HAH, and breathlessness was less marked, 
despite higher activity levels. This may reflect lower levels 
of anxiety within HAH: ‘Just so relaxed… content with the 
care… because when you’re anxious obviously it reacts on 
your breathing and your whole persona’ (P6L109–112). 
box 1 social constructions of hAh
Positive drivers for HAH
 ► Availability of home comforts and maintaining independence.
 – Perception of a quicker recovery with HAH and positive effects on 
perceived breathlessness.
 – Improved sleep and nutrition.
 – More convenient place to be with friends and family.
 ► Confidence in the continuity of HAH care.
 – Feelings of safety, reassurance and appreciation.
 – Personalised relation and specialist expertise of the RSN.
Potential barriers and negative influences for HAH care pathway
 ► Fear of being alone at home.
 ► Privacy issues and not wanting visitors.
 ► Resistance to change.
 – Reluctance to accept removal of nebulised therapy.
 – Challenging clinician’s preconceptions, accepting a new model of 
care and operational concerns.
 ► Negative influences of HAH.
Other insights
 ► Unintentional change in UC.
 ► Early uncertainty with HAH selected by DECAF.
DECAF, Dyspnoea, Eosinopenia, Consolidation, Acidaemia and atrial Fibrillation; 
HAH, hospital at home; RSN, respiratory specialist nurse; UC, usual care.
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Compared with UC, delays in obtaining reliever therapy 
were also avoided within HAH.
Improved sleep and nutrition
Patients reported sleep disruption in UC related to distur-
bances from other patients, nurses obtaining regular 
observations and new admissions while those who expe-
rienced HAH reported improved sleep: ‘There’s no bed 
like your own bed’ (N19L129).
Opinions were diverse concerning nutrition although 
most favoured HAH. ‘(I) liked hospital food and ate 
more in hospital than at home’ (P10L97) and, ‘You don’t 
eat the same in hospital for a start’ (P1L18).
More convenient place to be with friends and family
Home is more convenient and saves time and money for 
family and friends. Travel, car parking, work absences, 
childcare issues, restrictive visiting hours and hospital 
TV costs are avoided. ‘It’s easier for my family to visit… 
getting cars parked… when they have been to work all day 
by the time they get the hospital it’s time to come home’ 
(P22L21–24).
A key benefit of HAH was increased time with grand-
children: ‘When I’m in hospital I don’t see the grandchil-
dren. I’ve got six… and three of them live next door and 
they’re here every single day. When I’m not here they do 
cry; they get really upset’ (P13L167–169).
Carers reported that providing care at home was less 
disruptive, by avoiding hospital visits which take more 
time and organisation: ‘It’s better my husband being 
at home… instead of… going back and forward to the 
hospitals and especially with being a carer looking after 
two children’ (P17 L537– 548).
Confidence in the continuity of hAh care
Feelings of safety, reassurance and appreciation
Patients felt safe and reassured during HAH due to daily 
visits from the RSNs, the 24-hour telephone support line, 
confidence in the HAH clinical team and the availability 
of emergency services if return to hospital was needed. 
The evening phone call (9 pm) was reassuring to those 
patients living alone: ‘I had confidence in the team that 
came out… they all seemed to me to be very well trained 
and put me at ease’ (P1L71–74) and ‘If they thought you 
needed a doctor or the hospital they would phone an 
ambulance straight away’ (P12L320–327).
Most patients were not unduly concerned about poten-
tial delays in being seen by a doctor/clinician in the 
event of deterioration. ‘If your hospital at home, if you 
take really poorly yes you phone up… they will still be 
here as quick as they would if you were in a hospital’ 
(P12L319–327).
Within HAH, patients appreciated the ability to take 
their medication at their usual time, with immediate 
access to reliever therapy.
Personalised relation and specialist expertise of the RSN
Patients in HAH appreciated the better continuity in 
healthcare professionals compared with inpatient care 
and described the relationship with RSN as ‘personal’, 
‘individual’ and ‘one to one care’. Clinical assessments 
conducted at home provided privacy and were less rushed 
with ‘time to develop rapport’. Patients valued the clear 
explanations provided by RSNs during HAH about all 
aspects of their care, including monitoring, investigations 
and management, commenting that this may be lacking 
in hospital.
Some patients experienced a lack of dignity and 
privacy during UC. ‘A wash down behind the curtain, I 
was frightened, I was rushing’ (P32L53–55). Patients in 
UC acknowledged time constraints as a barrier towards 
personalised care, which was also recognised by the RSNs.
Discharge from UC incurs delays due to waiting for 
medication, discharge letter and transport. Such concerns 
were not raised about transfer home under HAH or 
subsequent discharge.
Potential barriers and negative influences for hAh care 
pathway
Fear of being alone at home
A common reason for declining participation in the 
RCT was fear of being alone when unwell, even when 
offered (same day) social support. The RSN stated 
that some patients were reluctant to accept social 
services because of perceived stigmatisation. ‘The 
hours I would be on my own… say I got up to go the 
toilet and my legs went what do you do then if you 
can’t breathe… you’ve got no phone at hand’ (D1, 
P2L39–41) and ‘They think if they’ve got a social 
worker or are involved with social services it’s like they 
are labelled… they wouldn’t realise they could just 
ring social services and ask for help’ (N4L102–104).
Participants recognised there may be a longer delay 
getting help if they deteriorated at home compared with 
in-hospital care. ‘Some people maybe prefer to be in a 
cocoon of a hospital environment; they maybe worry if 
something goes wrong someone’s seconds away from 
them’ (P1L226–229).
Privacy issues and not wanting visitors
Other decliners referred to privacy issues. ‘I thought 
people coming to my house, I cannot… I’m frightened 
that it wouldn’t be tidy’ (D3L4–7). For some, personal 
circumstances affected participation: ‘My husband and 
I are divorcing and my house just having been sold the 
atmosphere at home wouldn’t be conducive in recuper-
ating… but in the future… I would very much like to be 
involved’ (D9L14–21).
resistance to change
Reluctance to accept removal of nebulised therapy
During HAH, patients received similar treatment to 
those within UC, including controlled oxygen therapy, 
nebulised bronchodilators and intravenous medica-
tions if required. Patients reported that nebulised 
bronchodilators helped chest clearance as well as 
relieving breathlessness. Patients in HAH were more 
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likely to object to the removal of nebulised therapy 
than controlled oxygen. Similar objections were not 
raised to the same extent in UC. The challenge for the 
RSN was to reassure patients that such interventions 
were usually not required long term. ‘I think a lot of 
them have the misconception that if they have a nebu-
liser they are better… Your inhalers are far better 
more practical’ (N3L222–229).
Challenging clinicians’ preconceptions, accepting a new model of 
care and operational concerns
Physicians’ preconceptions included the view that 
hospital care provides respite for carers and ensures 
patients feel safer.‘The patient themselves may not 
be ready for it… I think they need to stay in hospital 
where they feel safer not because it is safer but basi-
cally they feel safer and also it gives a break (to) their 
carer’ (Co2 L53–66). Another physician disagreed, 
stating ‘That’s kind of often how people view patients 
with COPD that they want to come to hospital but 
actually it’s not true’ (Co3 L198–201).
Operational concerns included keeping medical 
records in a patient’s home and the inability to capture 
activity within current payment systems. ‘Our work in 
trying to get the centre to change the way… we can record 
the data for hospital at home patients… perhaps by us 
doing that it would make it easier for other trusts to go 
down the hospital home route in the future’ (M1L149–
153) and ‘If we are employing consultants, junior doctors, 
respiratory nurses, specialists nurses… and we are not 
having the patient in hospital so we are not getting the 
tariff for that… somebody has to pay the wage bill… and 
it’s about understanding that payment mechanism… 
then that becomes a lot easier for everybody because that 
is the kind of thing that will stop people moving forward’ 
(M17L183–193).
A different model of care requires adjustment. The 
RSNs advised that their confidence increased with expe-
rience of delivering HAH while patients mentioned that 
the quality of the service was dependent on the skill of 
the attending RSN. This highlights the importance of 
adequate training and support. ‘The only concern I 
would have is that hospital at home is only as good as the 
nurses you’ve got on’ (P12L336–337).
negative influences of hAh
Patients felt less inclined to smoke in hospital. ‘When 
I’m in hospital… I don’t think about smoking whatsoever 
where… at home I do’ (P14L273–276).
The hospital ward is an opportunity to establish new 
friendships that may continue postdischarge and patients 
were concerned that their relatives might be frightened 
seeing/knowing that they are unwell at home. ‘I’ve 
made some nice friends… still ring them… It was nice’ 
(P22L497–505). ‘It’s frightening for them to see when 
you’re not well it’s not nice for my husband to sit and 
watch us when I’m bad’ (P25L220–222).
Other insights
Unintentional change in UC
Despite efforts to ensure UC was not influenced by trial 
participation, patients were discharged home earlier 
than expected. Factors include physician awareness of 
low risk of death by DECAF, pressure from patients who 
were disappointed with allocation to UC and pressure 
from operational service managers. ‘There’s much more 
emphasis on getting people home early… the people who 
we aren’t (treating) in the hospital at home I think people 
are now more likely to send them home a lot earlier’ (Co3 
L120–126).
Early uncertainty with HAH selected by DECAF
Initially, some physicians expressed concern that, in their 
judgement, true risk for an individual patient was under-
estimated by DECAF. This led to delays in return home, 
which on occasion was unsettling for patients: ‘They have 
certain reservations, so you’ve got that conflict between 
their clinical impression and the predictive score…
the simple score almost always outperforms clinical 
judgement, but clinicians don’t like to think that’s true’ 
(Co18L40–52). With experience, physicians became 
more confident using DECAF and the safety within HAH 
model of care: ‘As you get evidence suggesting it works 
and it’s safe you’re more confident in doing it’ (Co6L154–
155). This was reflected in the wider HAH population as 
delayed return home was primarily an issue at the start of 
the trial.
I think part of the main advantage from my point of 
view is making me more aware of the safety of the 
DECAF score and the ability that people can be treat-
ed out of the hospital… whether that’s because of the 
hospital at home trial or… because of the gradual 
change in practice because of the DECAF score I’m 
not sure. (Co6L99–103)
Carers
In the RCT, 23 carers in HAH and 18 carers in UC 
completed Zarit Burden Interviews, including 13 of 15 
carers participating in this embedded qualitative study. 
Higher scores show higher levels of care burden. Baseline 
scores were similar in UC and HAH, but at 14 and 90 days 
scores were lower in HAH (table 2).
The percentage of patients with no change or an 
improvement in carer burden scores was higher in HAH, 
although this could be a chance finding.
DIsCussIOn
We interviewed 89 participants including patients, carers 
and healthcare professionals to inform implementation 
of our HAH model. While our RCT provides the justifi-
cation for the implementation of HAH regarding cost 
and clinical outcome, this qualitative study identifies the 
human and organisational factors that will influence its 
successful implementation. Positive drivers included the 
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following: greater independence and freedom; the main-
tenance of usual activities and perceived shorter recovery 
time; the maintenance of contact with friends and family 
(especially grandchildren); better sleep and more time 
spent with an expert healthcare professional. Reported 
barriers from patients included being alone at night and 
having ‘strangers’ visiting the home. Of note, some of 
these barriers, such as those relating to privacy and not 
wanting visitors, may be less of an issue at institutions 
which already have ESD.
Early concerns from some physicians and RSNs dimin-
ished with experience of successful delivery of this model 
of care. Two patients that were allocated to HAH were kept 
in hospital at the consultant’s discretion; this occurred in 
the first quarter of the study. Managers highlighted the 
inability for HAH activity to be captured within current 
payment systems. Hospitals planning to implement HAH 
selected by DECAF should pre-emptively address these 
issues. Compared with ESD, patients within HAH have 
higher clinical needs. Respiratory and Emergency Care 
Physicians require education, particularly highlighting 
the reliability of the DECAF score. RSNs delivering care 
at home require additional clinical training, consultant 
support and capacity to deliver the service. The HAH 
Manual and assessment sheets used within our service are 
available to facilitate this process. Of note, training costs 
were included in the health economic analysis, which 
showed that this model of care is cost-effective. Main-
taining clinical documents in a patient’s home should be 
supported by local agreement and patient consent.
The study has several key strengths. We used a qualita-
tive approach with semistructured interviews to explore the 
issues around HAH for those involved in the service.13 We 
performed a large number of interviews using purposeful 
sampling of patients to ensure both a wide range of partic-
ipants and perspectives.14 Not only were the experiences of 
patients and carers explored, but operational concerns from 
managers and clinicians were identified. Of note, we inter-
viewed patients who declined involvement in the trial: this is 
a group rarely included in such studies. The study sites had 
no HAH service prior to the RCT, so the emergent themes 
relate to HAH as a new service. This supports the transfer-
ability of our results to other institutions which lack this 
service. Finally, the views of carers were triangulated with the 
Zarit Burden Interview.
The study has several limitations. As with all qualitative 
research, it is impossible to fully remove observer bias. To 
minimise this risk, interviews were performed by a female 
trained health psychologist who was separate from the 
clinical team and had no previous experience or knowl-
edge in the design of the HAH care pathway, and three 
individuals independently performed analyses of the data 
to increase trust-worthiness and inter-rated reliability. 
Certain aspects, such as operational concerns, may only 
apply to the UK healthcare system. While the inclusion of 
interviewed personal was large and broad, other members 
of the multidisciplinary team such as physiotherapists 
may have provided useful insights. Finally, there is a risk 
of social desirability bias, in that interviewees may tell us 
what they think we want to hear. This was minimised by 
the interviewer emphasising that they were not involved 
in clinical care and that frank discourse would help 
develop the service.
Previous RCTs of domiciliary treatment for patients with 
ECOPD had more exclusion criteria than our RCT, and 
mostly were of ESD rather than HAH.15 Our RCT included 
patients typically deemed too unwell for home treatment 
in earlier studies, such as those with pneumonic ECOPD. 
Perceived risk remains a key factor for engagement, 
particularly during the early phase of service introduc-
tion, which will be important to address during educa-
tional sessions. In the DECAF study cohorts, 1266 of 2645 
patients were DECAF 0–1 (low risk), and risk of death 
remained low regardless of the index scoring. In the HoT 
DECAF RCT, there were no acute deaths.1 This is also in 
line with patient and carer perceptions in other trials. In 
a study of elderly patients, which included patients with 
ECOPD, substitutive HAH was reported as being safe by 
family and carers.16 Similar findings were shown in a study 
of six patients with ECOPD.17 In our study, patients and 
carers reported that HAH was safe, noting confidence in 
the clinical team and the availability of 24/7 telephone 
support, with return to hospital if required.
Five of thirteen patients who declined enrolment in the 
RCT reported fear of being home alone due to breath-
lessness, anxiety and/or problems coping at home. Three 
Table 2 Zarit Burden scores in carers
Count, n Median (IQR)
% Improved or same 
versus baseline Missing
Zarit Burden 0 day UC 18 18 (10–29) Ref 1
HAH 23 16 (10–30) Ref 0
Zarit Burden 14 day UC 18 23 (16–32) 35.7 3
HAH 23 13 (8–31) 57.9 4
Zarit Burden 90 day UC 18 25 (13–35) 16.7 5
HAH 23 14.5 (10–36) 27.8 5
HAH, hospital at home; UC, usual care.
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patients regretted not enrolling, and three declined partly 
because of unwell family members in the home. Despite the 
high rates of pneumonia and comorbidity, overall healthcare 
professionals were satisfied that the DECAF score selected 
low-risk patients suitable for HAH. In the whole HAH popu-
lation (n=60), there were only three instances of discordance 
between clinician judgement and the DECAF score leading 
to patients randomised to HAH receiving UC, all of whom 
survived for 90 days follow-up.
Carers of patients with COPD are at risk of various 
psychological health problems, such as anxiety and 
depression; partners of patients with COPD are typically 
elderly with their own health problems.18 Utens and 
others looked at carer strain in an RCT of ESD compared 
with UC, and showed no difference in the caregiver strain 
index between allocation groups.19 Given the higher 
treatment needs of patients in HAH, we anticipated that 
the carers of patients treated with HAH would report 
increased carer burden. However, carers reported that 
inpatient stay was more disruptive than HAH, both in 
terms of time and cost. This was supported by the Zarit 
Burden Interview scores, which showed that the median 
carer burden scores were numerically lower with HAH 
than UC, though this could have been a chance finding. 
While patients may express a fear of being or becoming 
a burden on their carers at the end of life,20 this was not 
reported in any of the interviews with patients in the 
context of HAH for an acute exacerbation.
HAH selected by DECAF allows the inclusion of more 
patients than existing models, is preferred to inpatient care 
by most patients and their families and is considered to be 
safe. HAH and the associated care were valued by many 
patients, in particularly with regards to continuity of care 
and in maintaining individuals’ independence. Following 
this study, HAH has been commissioned as a service for all 
patients with low-risk ECOPD. The results of this study, both 
in terms of potential drivers and barriers, are important 
areas of discussion when offering HAH to patients.
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